SciVision Biotech Inc. Statistics
SciVision Biotech Inc. (1786) Stock Statistics & Valuation Metrics
Total Valuation
SciVision Biotech Inc. has a market cap or net worth of TWD 3.52B. The enterprise value is TWD 2.77B.
- Market Cap
- TWD 3.52B
- Enterprise Value
- TWD 2.77B
Share Statistics
SciVision Biotech Inc. has 74,827,644 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 74,827,644
- Owned by Insiders
- ―
- Owned by Institutions
- 0.13%
Financial Efficiency
SciVision Biotech Inc.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 6.65%.
- Return on Equity (ROE)
- 0.08
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 6.65%
- Return on Capital Employed (ROCE)
- 0.08
- Revenue Per Employee
- 455.38K
- Profits Per Employee
- 83.38K
- Employee Count
- 1,947
- Asset Turnover
- 0.33
- Inventory Turnover
- 3.02
Valuation Ratios
The current PE Ratio of SciVision Biotech Inc. is 21.03. SciVision Biotech Inc.’s PEG ratio is 4.05.
- PE Ratio
- 21.03
- PS Ratio
- 4.19
- PB Ratio
- 2.12
- Price to FCF
- 70.67
- Price to Operating Cash Flow
- 31.93
- PEG Ratio
- 4.05
Income Statement
In the last 12 months, SciVision Biotech Inc. had revenue of 886.62M and earned 162.34M in profits. Earnings per share was 2.24.
- Revenue
- 886.62M
- Gross Profit
- 638.39M
- Operating Income
- 189.92M
- Pretax Income
- 185.04M
- Net Income
- 162.34M
- EBITDA
- 270.35M
- Earnings Per Share (EPS)
- 2.24
Cash Flow
In the last 12 months, operating cash flow was 118.78M and capital expenditures -66.01M, giving a free cash flow of 52.77M billion.
- Operating Cash Flow
- 118.78M
- Free Cash Flow
- 52.77M
- Free Cash Flow per Share
- 0.71
Dividends & Yields
SciVision Biotech Inc. pays an annual dividend of ―, resulting in a dividend yield of 4.06%
- Dividend Per Share
- ―
- Dividend Yield
- 4.06%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 1.42%
- Earnings Yield
- 4.70%
Stock Price Statistics
- Beta
- 0.38
- 52-Week Price Change
- -44.71%
- 50-Day Moving Average
- 43.15
- 200-Day Moving Average
- 54.47
- Relative Strength Index (RSI)
- 57.83
- Average Volume (3m)
- 370.78K
Important Dates
SciVision Biotech Inc. upcoming earnings date is Mar 11, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Mar 11, 2027
- Ex-Dividend Date
- ―
Financial Position
SciVision Biotech Inc. as a current ratio of 8.17, with Debt / Equity ratio of 24.50%
- Current Ratio
- 8.17
- Quick Ratio
- 7.70
- Debt to Market Cap
- 0.07
- Net Debt to EBITDA
- -1.33
- Interest Coverage Ratio
- 24.37
Taxes
In the past 12 months, SciVision Biotech Inc. has paid 22.70M in taxes.
- Income Tax
- 22.70M
- Effective Tax Rate
- 0.12
Enterprise Valuation
SciVision Biotech Inc. EV to EBITDA ratio is 13.51, with an EV/FCF ratio of 67.02.
- EV to Sales
- 3.98
- EV to EBITDA
- 13.51
- EV to Free Cash Flow
- 67.02
- EV to Operating Cash Flow
- 29.78
Balance Sheet
SciVision Biotech Inc. has TWD 905.67M in cash and marketable securities with TWD 485.61M in debt, giving a net cash position of TWD 420.05M billion.
- Cash & Marketable Securities
- TWD 905.67M
- Total Debt
- TWD 485.61M
- Net Cash
- TWD 420.05M
- Net Cash Per Share
- TWD 5.61
- Tangible Book Value Per Share
- TWD 24.05
Margins
Gross margin is 68.62%, with operating margin of 16.46%, and net profit margin of 20.03%.
- Gross Margin
- 68.62%
- Operating Margin
- 16.46%
- Pretax Margin
- 23.32%
- Net Profit Margin
- 20.03%
- EBITDA Margin
- 29.44%
- EBIT Margin
- 19.58%
Analyst Forecast
The average price target for SciVision Biotech Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -2.25%
- EPS Growth Forecast
- -15.57%
